Back to User profile » Dr Ping-Sheng Hao
Papers published by Dr Ping-Sheng Hao:
The IL-36 Cytokine Rheostat: Hierarchical Regulation of Epithelial–Immune Crosstalk and Precision Therapy in Psoriatic and Related Dermatoses
Qiao ZY, Liu JH, Luo NN, Tang L, Ma WY, Cheng ZL, Hao PS
Clinical, Cosmetic and Investigational Dermatology 2026, 19:594617
Published Date: 27 March 2026
A Bibliometric Analysis and Visualization of Research Trends and Hotspots in Actinic Keratosis Based on Web of Science
Cheng Z, Qiao Z, An S, Liu J, Ma W, Hao P
Clinical, Cosmetic and Investigational Dermatology 2025, 18:1507-1519
Published Date: 19 June 2025
Review of Excessive Cytosolic DNA and Its Role in AIM2 and cGAS-STING Mediated Psoriasis Development
Xu T, Zhong X, Luo N, Ma W, Hao P
Clinical, Cosmetic and Investigational Dermatology 2024, 17:2345-2357
Published Date: 22 October 2024
Inflammatory Memory in Epidermal Stem Cells - A New Strategy for Recurrent Inflammatory Skin Diseases
Gao Q, Hao PS
Journal of Inflammation Research 2024, 17:6635-6643
Published Date: 21 September 2024
Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review
Bo Y, Zhong X, Xiang Y, Ren Q, Hao P
Clinical, Cosmetic and Investigational Dermatology 2024, 17:941-951
Published Date: 27 April 2024
Genomics-Microbiome Based Assessment of Bidirectional Causality Between Gut Microbiota and Psoriasis
Gao Q, Liu JH, Ma WY, Cheng ZL, Hao PS, Luo NN
Clinical, Cosmetic and Investigational Dermatology 2024, 17:435-445
Published Date: 13 February 2024
Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review
Zhong X, Xu T, Li T, Luo N, Luo N, Hao P
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3157-3163
Published Date: 2 November 2023
Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
Liu JH, Gao Q, Ma WY, Cheng ZL, Luo NN, Hao PS
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1583-1587
Published Date: 20 June 2023
Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report
Luo N, Zhong L, Luo N, Wang Q, Li T, Hao P
Journal of Inflammation Research 2023, 16:2167-2172
Published Date: 19 May 2023
Tofacitinib for the Treatment of Steroid-Induced Rosacea
Li T, Wang H, Wang C, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2519-2521
Published Date: 23 November 2022
Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
Luo N, Wang Q, Lei M, Li T, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:1863-1867
Published Date: 12 September 2022
Burning and Scaling Probably Associated with Dupilumab Therapy: A Case Report
Luo N, Wang Q, Lei M, Li Z, Li T, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:1659-1662
Published Date: 17 August 2022
Facial Irritant Contact Dermatitis Caused by Pyraclostrobin
Wang Q, Luo N, Lei M, Zhong L, Li C, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:1643-1647
Published Date: 16 August 2022
Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report
Wang Q, Luo N, Lei M, Chen X, Li C, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:1371-1376
Published Date: 17 July 2022
Tofacitinib for Prurigo Nodularis: A Case Report
Peng C, Li C, Zhou Y, Wang Q, Xie P, Li T, Hao P
Clinical, Cosmetic and Investigational Dermatology 2022, 15:503-506
Published Date: 21 March 2022